The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects

Author:

Al-Salihi Karima A.1ORCID,Khalaf Jenan Mahmood2ORCID

Affiliation:

1. Department of Internal Medicine and Zoonotic Diseases, College of Veterinary Medicine, Al-Muthanna University, Al-Muthanna Province, Iraq.

2. Department of Internal and Preventive Medicine, Unit of Zoonotic Diseases, College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq.

Abstract

Zoonotic coronavirus disease (COVID) has emerged in the past two decades and caused a pandemic that has produced a significant universal health alarm. Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome-CoV (MERS-CoV) emerged in 2002 and 2012, respectively, provoking severe lower respiratory infection and deadly pneumonia. COVID-19 is a severe respiratory disease caused by the new strain of novel CoV (SARS-CoV-2). The zoonotic aspects of the SARS-CoV-2 in comparison to SARS-CoV and MERS-CoV are highlighted in this article. COVID-19 has rapidly become a pandemic and has spread and infected millions of people worldwide. As of November 19, 2020, the date of submitting this review, the total CoV cases, deaths, and recovered patients are 56,828,218, 1,359,320, and 39,548,923, respectively. In conclusion, COVID-19 has particularly altered the opinion of the significance of zoonotic diseases and their animal origins and the intermediate reservoirs, which may be unknown wild animals. Genetically, the SARS-CoV-2 is related to the SARS-like bat CoVs and shares 85% identity with the SARS-CoV that is derived from the SARS-like bat CoVs. However, the virus is related to a lesser extent to the MERS-CoV. The SARS-CoV-2 uses the same receptor-binding domain receptor of the SARS-CoV – the angiotensin-converting enzyme 2; conversely, DPP4 (CD26). It has not been proved that the MERS-CoVs primary receptor is the receptor of the SARS-CoV-2.

Publisher

Veterinary World

Subject

General Veterinary

Reference78 articles.

1. Biscayart, C., Angeleri, P., Lloveras, S., Chaves, T.D., Schlagenhauf, P. and Rodríguez-Morales, A.J. (2020) The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med. Infect. Dis., 33: 101567.

2. Durham, P.J., Stevenson, B.J. and Farquharson, B.C. (1979) Rotavirus and coronavirus associated diarrhea in domestic animals. N. Z. Vet. J., 27(3): 30-32.

3. Weiss, S.R. and Leibowitz, J.L. (2011) Coronavirus pathogenesis. Adv. Virus Res., 81: 85-164.

4. Masters, P.S. and Perlman, S. (2013) Coronaviridae. In: Knipe, D.M., Howley, P.M., editors. Fields Virology. 6th ed. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania. p825-858.

5. Fehr, A.R. and Perlman, S. (2015) Coronaviruses: An overview of their replication and pathogenesis. Methods Mol. Biol., 1282: 1-23.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3